MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Clinical trials for MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE trials appear
Sign up with your email to follow new studies for MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study aims to catch and control fatty liver disease in kids without drugs
Disease control OngoingThis study focuses on children aged 7 to 11 who are overweight and at risk for MASLD, a common liver condition. Researchers are testing a simple waist measurement (waist-to-height ratio) as a screening tool and will evaluate a lifestyle program involving school, clinic, family, a…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Ningbo No. 1 Hospital • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Diet showdown: can fasting beat pills for fatty liver disease?
Disease control ENROLLING_BY_INVITATIONThis study tests whether a Mediterranean diet combined with intermittent fasting can reduce liver scarring better than the weight-loss medication naltrexone/bupropion. About 70 adults with overweight, type 2 diabetes, or other heart-related risks and moderate liver fibrosis will …
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE4 • Sponsor: Carmen Dietvorst • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
Major study aims to end painful liver biopsies for thousands
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 1,689 adults with fatty liver disease (MASLD) to see if non-invasive tests like MRI and Fibroscan can accurately track disease progression and treatment response. The goal is to reduce the need for liver biopsies in future research and routine care. Participant…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: HRI-MAIL-NIT • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC
-
Researchers track fatty liver disease in diabetes patients to predict who gets worse
Knowledge-focused ENROLLING_BY_INVITATIONThis study re-examines 317 adults with type 2 diabetes who were first checked for fatty liver disease a few years ago. Researchers will use advanced scans and blood tests to see if their liver condition has improved, worsened, or stayed the same. The goal is to find patterns and …
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Linkoeping University • Aim: Knowledge-focused
Last updated May 11, 2026 20:46 UTC